Effect of N-(4-hydroxyphenyl)retinamide on apoptosis in human breast cancer cells

Cancer Letters

Volumn 107, Issue 1, 1996, Pages 65-71

  Wang, Thomas T Y ^a   Phang, James M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Bax; Bcl 2; Breast cancer; Estradiol; Retinoids

Indexed keywords

ESTROGEN RECEPTOR; FENRETINIDE; MESSENGER RNA;

APOPTOSIS; ARTICLE; BREAST CANCER; CHEMOPROPHYLAXIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL;

EID: 0030271586     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04344-3     Document Type: Article

References (19)

1. [1] Kerr, J.F.R., Wyllie, A.H. and Currie, A.R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br. J. Cancer, 26, 239-257.
2. [2] Carson, D.A. and Ribeiro, J.M. (1993) Apoptosis and disease. Lancet, 341, 1251-1254.
3. [3] Mikulski, S.M. (1994) Pathogenesis of cancer in view of mutually opposing apoptotic and anti-apoptotic growth signals (Review), Int. J. Oncol., 4, 1257-1263.
4. [4] Reed, J.C. (1994) Bcl-2 and the regulation of programmed cell death, J. Cell Biol., 124, 1-6.
5. [5] Oltvai, Z.N., Milliman, C.L. and Korsmeyer, S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog Bax, that accelerates programmed cell death, Cell, 74, 609-619.
6. [6] Sato, T., Hanada, M,, Bodrug, S., Irie, S., Iwama, N., Boise, L.H., Thompson, C.B., Golemis, E., Fong, L., Wang, H.-G. and Reed, J.C. (1994) Interaction among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system, Proc. Natl. Acad. Sci. USA., 91, 9238-9242.
7. [7] Sabourin, J.C., Martin, A., Baruch, J., Truc, J.B., Gompel, A. and Poitout, P. (1994) bcl-2 expression in normal breast tissue during the menstrual cycle, Int. J. Cancer, 59, 1-6.
8. [8] Gee, J.M.W., Robertson, J.F.R., Ellis, I.O., Willsher, P., McClelland, R.A., Hoyle, H.B., Kyme, S.R., Finlay, P., Blamey, R.W. and Nicholson, R.I. (1994) Immunocytochemical localization of Bcl-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy, Int. J. Cancer, 59, 619-628.
9. [9] Wang, T.T.Y. and Phang, J.M. (1995) Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7, Cancer Res., 55, 2487-2489.
10. [10] Teixeria, C., Reed, J.C. and Pratt, M.A.C. (1995) Estrogen promotes chemotherapeutic drug resistance by a mechanism involving bcl-2 proto-oncogene expression in human breast cancer cells, Cancer Res., 55, 3902-3907.
11. [11] Nenci, I., Marchetti, E. and Querzoli, P. (1988) Commentary on human mammary preneoplasia: the estrogen receptor-promotion hypothesis, J. Steroid Biochem., 30, 105-106.
12. [12] Boone, C.W., Kelloff, G.J. and Malone, W.E. (1990) Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review, Cancer Res., 50, 2-9.
13. [13] Marth, C., Bock, G. and Daxenbichler, G. (1985) Effect of 4-hydroxyphenylretinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells, J. Natl. Cancer Inst., 75, 871-875.
14. [14] Cobleigh, M.A., Dowlatshahi, K., Deutsch, T.A., Mehta, R.G., Moon, R.C., Minn, F., Benson III, A.B., Rademake, A.W., Ashenhurst, J.B., Wade III, J.L. and Wolter, J. (1993) PhaseI/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in woman with metastatic breast cancer, J. Clin. Oncol., 11, 474-477.
15. [15] Delia, D., Aiello, A., Formelli, F., Fontanella, E., Costa, A., Miyashita, T., Reed, J.C. and Pierotti, M.A. (1995) Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl)retinamide and effect of deregulated bcl-2, Blood, 85, 359-367.
16. [16] Ponzoni, M., Bocca, P., Chiesa, V., Decensi, A., Pistoia, V., Raffaghello, L., Rozzo, C. and Montaldo, P.G. (1995) Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation, Cancer Res., 55, 853-861.
17. [17] Wang, T.T.Y., Sathyamoorthy, N. and Phang, J.M. (1996) Molecular effects of genistein on the estrogen receptor mediated pathway, Carcinogenesis, 17, 271-275.
18. [18] Demirpence, E., Balagur, P., Trousse, F., Nicolas, J.-C., Pons, M. and Gague, D. (1994) Antiestrogenic effects of all-transretinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanism, Cancer Res., 54, 1458-1464.
19. [19] Haldar, S., Negrini, M., Monne, M., Sabbioni, S. and Croce, C.M. (1994) Down-regulation of bcl-2 by p53 in breast cancer cells, Cancer Res., 54, 2095-2097.